MétaCan
Menu
← Back to cohort

Feasibility of daily physical activity monitoring and associations with treatment toxicity in older adults with metastatic prostate cancer.

2023· article· en· W4379280640 on OpenAlexafffundabout
Gregory Feng, Milothy Parthipan, Henriette Breunis, Narhari Timilshina, Enrique Soto‐Pérez‐de‐Celis, Daniel Santa Mina, Urban Emmenegger, Aaron R. Hansen, Antonio Finelli, George Tomlinson, Monika K. Krzyzanowska, Andrew Matthew, Hance Clarke, Martine Puts, Shabbir M.H. Alibhai

Bibliographic record

VenueJournal of Clinical Oncology · 2023
Typearticle
Languageen
FieldMedicine
TopicCancer survivorship and care
Canadian institutionsSunnybrook Health Science CentreUniversity of TorontoPrincess Margaret Cancer CentreHealth Sciences CentreUniversity Health Network
FundersProstate Cancer Canada
KeywordsMedicineProstate cancerProspective cohort studyGeneralizability theoryEnzalutamideLogistic regressionCohortInternal medicinePhysical therapyActivities of daily livingCancerOncology

Abstract

fetched live from OpenAlex

12055 Background: Accelerometry research suggests physical activity may be associated with treatment toxicity, but generalizability to geriatric oncology is unclear. As many older adults have low levels of physical activity and technology use, further exploration is warranted. This study explores the feasibility of daily physical activity monitoring and the association between step counts and symptoms. Methods: Older adults aged 65+ starting treatment (chemotherapy, enzalutamide/abiraterone, or Radium-223) for metastatic prostate cancer were enrolled in a prospective cohort study. Participants reported step counts (measured via smartphone and a free commercial app) and symptoms (Edmonton Symptom Assessment Scale (ESAS)) daily for their first treatment cycle (~1 month). The feasibility of daily monitoring was assessed with descriptive statistics and thematic analysis. The association between a 15% decline in steps (compared to pre-treatment baseline) and the emergence of moderate-to-severe symptoms and pain (ESAS ≥4) in the next 24 hours was assessed using logistic regression. The utility of a 15% step count decline in predicting the development of moderate-to-severe symptoms and pain was evaluated using sensitivity and positive predictive value (PPV). Results: Of 90 participants, 47 engaged in step count monitoring (mean age 75y; 52.2% participation rate). Daily physical activity monitoring was found to be feasible (90.5% median response rate; 94% retention rate) with numerous patient-reported benefits including increased self-awareness and motivation to engage in physical activity. During the first treatment cycle, instances of a 15% decline in steps were common (n=37, 78.7%), as was the emergence of moderate-to-severe symptoms overall (n=40, 85.1%) and pain (n=26, 55.3%). Overall, daily physical activity did not appear to be significantly predictive of symptoms (OR=1.8, 95% CI=0.42-7.74) overall or pain (OR=0.95, 95% CI=0.22-3.81). Predictive validity estimates revealed reasonable sensitivity for both moderate to severe symptoms overall (sensitivity=88.8%, 95% CI=68.7-95.0; PPV=73.0%, 95% CI=58.7-87.3) but poor PPV for pain (sensitivity=77.8%, 95% CI=58.6-97.0; PPV=37.8%, 95% CI=22.2-53.5). Conclusions: Despite recent studies framing physical activity changes as predictive of toxicity, PPV was only poor to fair. However, daily activity monitoring in older cancer patients appears feasible and may have other uses. Clinical trial information: NCT04193657 .

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.011
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.017

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.011
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.125
GPT teacher head0.479
Teacher spread0.354 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes3
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicCancer survivorship and care→French-language works237,207→